Studies consistently report reduced symptoms, bloating, constipation and pain, plus improvements in anxiety and mood — two dimensions that feed IBS. In head-to-head comparisons there is no significant difference between biofeedback and hypnotherapy or cognitive therapy; but in the largest trial a well-designed placebo group improved with no significant difference from the full treatment.
AAPB4EfficaciousNeuroLogic4Efficacioussame vs AAPB
Level 4 maintained. AAPB base: the Albany multicomponent package (education, relaxation, thermal biofeedback, cognitive stress coping) superior to symptom monitoring in Neff & Blanchard 1987 (n = 19, 6 of 10 trained improved by 50 % or more), Gerardi 1987 (n = 30, attention-placebo control) and Blanchard 1992 (n = 30 then n = 92, six of seven symptom areas reduced), with documented benefit at 1, 2 and 4 years (Schwarz 1986, Blanchard 1988, Schwarz 1990: 17 of 19 patients rating themselves at least 50 % improved). HRV biofeedback: no significant difference from gut-directed hypnotherapy in Dobbin 2013 (n = 128 randomised, 61 completers, three sessions) or from cognitive therapy in Thompson 2010 (n = 37). In Blanchard 1992 the attention placebo did not differ significantly from the full package, which rules out Level 5. Goldenberg 2019's Cochrane review (8 studies, n = 300) judges the evidence insufficient; we weigh the consistency of results and the active comparators instead. 2022-2026 window: Minjoz 2025 (n = 29, control period then home HRV practice, reduced psychological distress and sympathetic reactivity, no gastrointestinal outcome) and Younginer 2026 (virtual group CBT + HRV biofeedback vs waitlist; adolescent IBS subgroup n = 21 with no significant quality-of-life change) add nothing decisive.
In short
Clinical reading
AAPB Level 4; NeuroLogic Level 4. Base: the Albany multicomponent package superior to symptom monitoring (Neff & Blanchard 1987, Gerardi 1987, Blanchard 1992) with 1-, 2- and 4-year follow-up; HRV with no significant difference from hypnotherapy (Dobbin 2013) or cognitive therapy (Thompson 2010). Modalities have evolved: bowel-sound and rectosigmoid feedback in the 1980s, electrodermal later, HRV since 2010. Not Level 5: in Blanchard 1992 the attention placebo did not differ significantly from treatment.
Protocols
Resonance-frequency HRV, thermal biofeedback within a multicomponent package (education, relaxation, stress coping), electrodermal; for associated dyssynergic defecation, anorectal coordination EMG.
Limits
Highly heterogeneous modalities across decades; older studies have design weaknesses and non-standardised symptom measures; the HRV trials are brief with no no-treatment arm; strong placebo response in IBS; paediatric evidence is nearly absent (one HRV clinical series, one null adolescent subgroup in 2026), hence no paediatric row.
Study base
Continuous literature since the 1980s, with follow-ups at one year and beyond; Cochrane review 2019 (8 studies, n = 300). 2022-2026 base: 4 publications indexed in the archive (3 HRV, 1 anorectal biofeedback).
Brendan's perspective
Level 4 is right and I would not move it. The Albany package beat symptom monitoring across Neff & Blanchard 1987, Gerardi 1987 and Blanchard 1992, and held at one, two and four years, which is more than most of this field can say. What keeps it off level 5 is in the data itself: in Blanchard 1992 the attention placebo did not differ significantly from the full package. Dobbin 2013 and Thompson 2010 show no significant difference from hypnotherapy and from cognitive therapy — that is a null against an active comparator in small samples, not equivalence, and those trials were not designed to test equivalence. My own use here is resonance-frequency HRV inside a broader package, because an unregulated autonomic system is the noise the gut keeps reporting; three to eight sessions on a home device is not a serious dose. Tell the client that biofeedback is one credible option among several, and that IBS responds strongly to attention and expectation.
Blanchard et al. (1992) Two controlled evaluations of multicomponent psychological treatment of irritable bowel syndrome doi:10.1016/0005-7967(92)90141-3
Schwarz et al. (1990) Behaviorally treated irritable bowel syndrome patients: A four-year follow-up doi:10.1016/0005-7967(90)90085-W
Dobbin et al. (2013) Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome doi:10.4997/JRCPE.2013.104
